BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20880582)

  • 1. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function.
    Kim SE; Song SH; Yun YP; Choi BJ; Kwon IK; Bae MS; Moon HJ; Kwon YD
    Biomaterials; 2011 Jan; 32(2):366-73. PubMed ID: 20880582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration.
    Lee DW; Yun YP; Park K; Kim SE
    Bone; 2012 Apr; 50(4):974-82. PubMed ID: 22289658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of titanium with heparin/BMP-2 complex for improving osteoblast activity.
    Lee SY; Yun YP; Song HR; Chun HJ; Yang DH; Park K; Kim SE
    Carbohydr Polym; 2013 Oct; 98(1):546-54. PubMed ID: 23987380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration.
    Shi Z; Neoh KG; Kang ET; Poh CK; Wang W
    Biomacromolecules; 2009 Jun; 10(6):1603-11. PubMed ID: 19391583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of titanium with hydroxyapatite-heparin-BMP-2 enhances the efficacy of bone formation and osseointegration in vitro and in vivo.
    Yang DH; Lee DW; Kwon YD; Kim HJ; Chun HJ; Jang JW; Khang G
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1067-77. PubMed ID: 25524250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function.
    Moon HJ; Yun YP; Han CW; Kim MS; Kim SE; Bae MS; Kim GT; Choi YS; Hwang EH; Lee JW; Lee JM; Lee CH; Kim DS; Kwon IK
    Biochem Biophys Res Commun; 2011 Sep; 413(2):194-200. PubMed ID: 21888898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast progenitor cell responses to characterized titanium surfaces in the presence of bone morphogenetic protein-atelopeptide type I collagen in vitro.
    Ong JL; Bess EG; Bessho K
    J Oral Implantol; 1999; 25(2):95-100. PubMed ID: 10551143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography.
    Boyan BD; Bonewald LF; Paschalis EP; Lohmann CH; Rosser J; Cochran DL; Dean DD; Schwartz Z; Boskey AL
    Calcif Tissue Int; 2002 Dec; 71(6):519-29. PubMed ID: 12232675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phosphoric acid treatment of titanium surfaces on surface properties, osteoblast response and removal of torque forces.
    Park JW; Kim YJ; Jang JH; Kwon TG; Bae YC; Suh JY
    Acta Biomater; 2010 Apr; 6(4):1661-70. PubMed ID: 19819355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Modification of Titanium with BMP-2/GDF-5 by a Heparin Linker and Its Efficacy as a Dental Implant.
    Yang DH; Moon SW; Lee DW
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface.
    Bae SE; Choi J; Joung YK; Park K; Han DK
    J Control Release; 2012 Jun; 160(3):676-84. PubMed ID: 22543042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced osteoblast response to hydrophilic strontium and/or phosphate ions-incorporated titanium oxide surfaces.
    Park JW; Kim YJ; Jang JH
    Clin Oral Implants Res; 2010 Apr; 21(4):398-408. PubMed ID: 20128830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion.
    Hu X; Neoh KG; Shi Z; Kang ET; Poh C; Wang W
    Biomaterials; 2010 Dec; 31(34):8854-63. PubMed ID: 20800276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
    Kodama T; Goto T; Miyazaki T; Takahashi T
    Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced osteogenic differentiation of MC3T3-E1 on rhBMP-2-immobilized titanium via click reaction.
    Kim EC; Kim TH; Jung JH; Hong SO; Lee DW
    Carbohydr Polym; 2014 Mar; 103():170-8. PubMed ID: 24528716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-functionalized adhesive polymer nanoparticles for controlled local release of bone morphogenetic protein-2 from titanium surface.
    Lee HJ; Koo AN; Lee SW; Lee MH; Lee SC
    J Control Release; 2013 Sep; 170(2):198-208. PubMed ID: 23727196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of platelet-derived growth factor (PDGF-BB) and bone morphogenic protein (BMP-2) coated onto heparinized titanium for improving osteoblast function and osteointegration.
    Kim SE; Yun YP; Lee JY; Shim JS; Park K; Huh JB
    J Tissue Eng Regen Med; 2015 Dec; 9(12):E219-28. PubMed ID: 23288808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving osteoblast functions and bone formation upon BMP-2 immobilization on titanium modified with heparin.
    Kim SE; Kim CS; Yun YP; Yang DH; Park K; Kim SE; Jeong CM; Huh JB
    Carbohydr Polym; 2014 Dec; 114():123-132. PubMed ID: 25263872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions.
    Shi Z; Neoh KG; Kang ET; Poh C; Wang W
    Tissue Eng Part A; 2009 Feb; 15(2):417-26. PubMed ID: 18837650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.